Literature DB >> 17326644

A new and efficient strategy for the synthesis of podophyllotoxin and its analogues.

Yingming Wu1, Hongbin Zhang, Yuanhong Zhao, Jingfeng Zhao, Jingbo Chen, Liang Li.   

Abstract

[structure: see text]. An efficient and stereoselective strategy for the total synthesis of podophyllotoxin was developed. This route leads to podophyllotoxin 1 in only 12 steps with 29% overall yield. A notable feature of this synthetic strategy is the use of the cascade addition-alkylation to ensure the key C1-C2 stereochemistry that is pivotal for the synthesis of podophyllotoxin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17326644     DOI: 10.1021/ol0630954

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  Next generation sequencing in predicting gene function in podophyllotoxin biosynthesis.

Authors:  Joaquim V Marques; Kye-Won Kim; Choonseok Lee; Michael A Costa; Gregory D May; John A Crow; Laurence B Davin; Norman G Lewis
Journal:  J Biol Chem       Date:  2012-11-16       Impact factor: 5.157

Review 2.  Recent strategies and tactics for the enantioselective total syntheses of cyclolignan natural products.

Authors:  Rebekah G Reynolds; Huong Quynh Anh Nguyen; Jordan C T Reddel; Regan J Thomson
Journal:  Nat Prod Rep       Date:  2022-03-23       Impact factor: 13.423

3.  Investigation and Expression of the Secoisolariciresinol Dehydrogenase Gene Involved in Podophyllotoxin Biosynthesis.

Authors:  Sonja L B Arneaud; John R Porter
Journal:  Mol Biotechnol       Date:  2015-12       Impact factor: 2.695

4.  Thiols oxidation and covalent binding of BSA by cyclolignanic quinones are enhanced by the magnesium cation.

Authors:  Antonio E Alegria; Pedro Sanchez-Cruz; Ajay Kumar; Carmelo Garcia; Fernando A Gonzalez; Aimee Orellano; Beatriz Zayas; Marina Gordaliza
Journal:  Free Radic Res       Date:  2008-01

5.  Production of podophyllotoxin from roots and plantlets of Hyptis suaveolens cultivated in vitro.

Authors:  Rafael A Velóz; Alexandre Cardoso-Taketa; María Luisa Villarreal
Journal:  Pharmacognosy Res       Date:  2013-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.